Free tool
Diagnostics stocks
We cover 32 companies grouped under the Diagnostics theme. The median market value in the group is $47.65M. Across the group, the median move over the past trading day is +1.20%. 52% of the 31 with a 200-day average trade above it. Price change over the past year runs from −90.8% to +147.4% across the middle 80 percent of the group, with a median of −22.3%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
32 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| QGEN | Qiagen N.V. | $9.01B | Mid cap | −10.74% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| BLLN | BillionToOne, Inc. | $4.72B | Mid cap | −8.14% |
| ADPT | Adaptive Biotechnologies Corporation | $4.19B | Mid cap | +107.18% |
| GRAL | GRAIL, Inc. | $3.69B | Mid cap | +150.69% |
| VCYT | Veracyte, Inc. Common Stock | $3.54B | Mid cap | +49.04% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| WGS | GeneDx Holdings Corp. | $2.61B | Mid cap | −28.28% |
| NEOG | Neogen Corporation | $2.54B | Mid cap | +107.86% |
| NEO | NeoGenomics, Inc. | $2.19B | Mid cap | +160.31% |
| SERA | Sera Prognostics, Inc. | $86.00M | Micro cap | −17.42% |
| MDXH | MDxHealth SA | $70.73M | Micro cap | −83.84% |
| KVAC | Keen Vision Acquisition Corp | $63.38M | Micro cap | +4.43% |
| DXR | Daxor Corporation | $58.38M | Micro cap | −7.83% |
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $54.52M | Micro cap | +6.62% |
| PAVM | PAVmed Inc. | $40.78M | Micro cap | −64.04% |
| ADVB | Advanced Biomed Inc. | $15.17M | Micro cap | −4.38% |
| CODX | Co-Diagnostics, Inc. | $7.63M | Micro cap | −87.07% |
| ACON | Aclarion, Inc. | $7.18M | Micro cap | −65.89% |
| INBS | Intelligent Bio Solutions Inc. | $7.12M | Micro cap | −83.95% |
| NDRA | ENDRA Life Sciences Inc. | $6.84M | Micro cap | +6.74% |
| AIDX | 20/20 Biolabs, Inc. | $6.75M | Micro cap | −97.79% |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.65M | Micro cap | −45.58% |
| BMRA | Biomerica, Inc. | $5.47M | Micro cap | −48.40% |
| VNRX | VolitionRx Limited | $5.25M | Micro cap | −97.21% |
| BGLC | BioNexus Gene Lab Corp. | $4.55M | Micro cap | −72.52% |
| REVB | Revelation Biosciences, Inc. | $3.98M | Micro cap | −91.21% |
| BIAF | bioAffinity Technologies, Inc. | $3.14M | Micro cap | −30.52% |
| ONCO | Onconetix, Inc. | $2.54M | Micro cap | −99.57% |
| VRAX | Virax Biolabs Group Limited | $2.32M | Micro cap | +275.97% |
| BJDX | Bluejay Diagnostics, Inc. | $948.00K | Micro cap | −83.87% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.